Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial

Background/Aims A clinical unmet need persists for medications capable of modulating the progression of primary sclerosing cholangitis (PSC). This study aimed to assess the clinical feasibility of HK-660S (beta-lapachone) in PSC. Methods In this multicenter, randomized, double-blind, placebo-control...

Cijeli opis

Bibliografski detalji

Glavni autori:	Woo Hyun Paik, Joo Kyung Park, Moon Jae Chung, Gunn Huh, Ce Hwan Park, Sang Hyub Lee, Heon Se Jeong, Hee Jin Kim, Do Hyun Park
Format:	Artigo
Jezik:	Inglês
Izdano:	Korean Association for the Study of the Liver 2025-01-01
Serija:	Clinical and Molecular Hepatology
Teme:	primary sclerosing cholangitis lapachone cholangiopancreatography, magnetic resonance alkaline phosphatase nicotinamide adenine dinucleotide
Online pristup:	http://e-cmh.org/upload/pdf/cmh-2024-0629.pdf
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!